BA

Boopathy Alagersamy

Active Director Director DIN 11076668
DIN 11076668 First appointment Apr 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Boopathy Alagersamy

Data last updated:

Boopathy Alagersamy is a Director at Madras Implants Private Limited (since 2025). The company operates in Healthcare.

DIN 11076668
Primary Designation Director
Industry Healthcare
First Appointment 25 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Madras Implants Private Limited U32509TN2025PTC179851
Director25 Apr 20252025Active

Board colleagues of Boopathy Alagersamy

Directorship timeline

Open interactive timeline →
Madras Implants Private Limited
Premium access

Shareholding and investment profile for Boopathy Alagersamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Boopathy Alagersamy

Boopathy Alagersamy currently holds 1 directorship: Madras Implants Private Limited (Director, since 25 Apr 2025).

Boopathy Alagersamy was first appointed on 25 Apr 2025 as Director at Madras Implants Private Limited.

The current boards of Boopathy Alagersamy's companies include Ganesh Subramaniyam (Madras Implants Private Limited), Padma (Madras Implants Private Limited), Sriraam Sambandam Ramanathan (Madras Implants Private Limited), Venkatadoss Satheeshbabu (Madras Implants Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available